REGENXBIO
RGNX
$16.11
Share price
-5.40%
Change (1 day)
-14.72%
Change (1 year)
Categories
Earnings for REGENXBIO (RGNX)
Earnings in 2023 (TTM): -$0.26 B
According to REGENXBIO's latest financial reports the company's current earnings (TTM) are -$0.26 B. In 2022 the company made an earning of -$0.26 B a decrease over its 2021 earnings that were of $0.16 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for REGENXBIO from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.26 B | -0.14% |
| 2022 | -$0.26 B | -253.5% |
| 2021 | $0.16 B | -259.29% |
| 2020 | -$0.11 B | -29.42% |
| 2019 | -$0.15 B | -269.12% |
| 2018 | $88.1 M | -216.1% |
| 2017 | -$75.89 M | 19.69% |
| 2016 | -$63.41 M | 178.03% |
| 2015 | -$22.81 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -56.86% | 🇺🇸 USA |